107 related articles for article (PubMed ID: 28558926)
1. Using PICO Methodology to Answer Questions About Smoking in COPD Patients.
Jiménez Ruiz CA; Buljubasich D; Riesco Miranda JA; Acuña Izcaray A; de Granda Orive JI; Chatkin JM; Zabert G; Guerreros Benavides A; Paez Espinel N; Noé V; Sánchez-Angarita E; Núñez-Sánchez I; Sansores RH; Casas A; Palomar Lever A; Alfageme Michavila I
Arch Bronconeumol; 2017 Nov; 53(11):622-628. PubMed ID: 28558926
[TBL] [Abstract][Full Text] [Related]
2. Treatment of smoking in smokers with chronic obstructive pulmonary disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
Jiménez-Ruiz CA; Riesco Miranda JA; Altet Gómez N; Lorza Blasco JJ; Signes-Costa Miñana J; Solano Reina S; de Granda Orive JI; Ramos Pinedo A; Martinez Muñiz MA; Barrueco Ferrero M;
Arch Bronconeumol; 2013 Aug; 49(8):354-63. PubMed ID: 23642760
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness of varenicline for smoking cessation.
Keiding H
Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the effectiveness of smoking cessation in the management of COPD.
Temitayo Orisasami I; Ojo O
Br J Nurs; 2016 Jul; 25(14):786-91. PubMed ID: 27467642
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand.
Tosanguan J; Chaiyakunapruk N
Addiction; 2016 Feb; 111(2):340-50. PubMed ID: 26360507
[TBL] [Abstract][Full Text] [Related]
6. If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands.
Vemer P; Rutten-van Mölken MP; Kaper J; Hoogenveen RT; van Schayck CP; Feenstra TL
Addiction; 2010 Jun; 105(6):1088-97. PubMed ID: 20659063
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for the Treatment of Smoking in Hospitalized Patients.
Jiménez Ruiz CA; de Granda Orive JI; Solano Reina S; Riesco Miranda JA; de Higes Martinez E; Pascual Lledó JF; Garcia Rueda M; Lorza Blasco JJ; Signes Costa-Miñana J; Valencia Azcona B; Villar Laguna C; Cristóbal Fernández M
Arch Bronconeumol; 2017 Jul; 53(7):387-394. PubMed ID: 28017455
[TBL] [Abstract][Full Text] [Related]
8. Principles of confrontational counselling in smokers with chronic obstructive pulmonary disease (COPD).
Kotz D; Huibers MJ; Vos R; van Schayck CP; Wesseling G
Med Hypotheses; 2008; 70(2):384-6. PubMed ID: 17604568
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany.
Aumann I; Treskova M; Hagemann N; von der Schulenburg JM
Appl Health Econ Health Policy; 2016 Aug; 14(4):441-452. PubMed ID: 27021824
[TBL] [Abstract][Full Text] [Related]
10. Questions and Answers on Smoking in Patients With Diffuse ILD. Use of PICO Methodology.
Jiménez-Ruiz CA; Zabert G; Buljubasich D; de Granda-Orive JI; Buendía I; Luhning S; Rodriguez-Portal JA; Caro F; Albert ML; Riesco-Miranda JA; Borrajo C; Sánchez-Angarita E; Acuña-Izcaray A
Arch Bronconeumol (Engl Ed); 2020 Jul; 56(7):435-440. PubMed ID: 31753676
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of spirometry as a motivational tool for smoking cessation: a clinical trial, the ESPIMOAT study.
Irizar-Aramburu MI; Martínez-Eizaguirre JM; Pacheco-Bravo P; Diaz-Atienza M; Aguirre-Arratibel I; Peña-Peña MI; Alba-Latorre M; Galparsoro-Goikoetxea M
BMC Fam Pract; 2013 Dec; 14():185. PubMed ID: 24308728
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
Lutz MA; Lovato P; Cuesta G
Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
[TBL] [Abstract][Full Text] [Related]
13. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
Lutz MA; Lovato P; Cuesta G
Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
[TBL] [Abstract][Full Text] [Related]
14. Varenicline in the management of smoking cessation: a single technology appraisal.
Hind D; Tappenden P; Peters J; Kenjegalieva K
Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
[TBL] [Abstract][Full Text] [Related]
15. Smoking cessation treatment for COPD smokers: the role of counselling.
Jiménez-Ruiz CA; Fagerström KO
Monaldi Arch Chest Dis; 2013 Mar; 79(1):33-7. PubMed ID: 23741944
[TBL] [Abstract][Full Text] [Related]
16. Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.
Jiménez-Ruiz CA; Solano-Reina S; Signes-Costa J; de Higes-Martinez E; Granda-Orive JI; Lorza-Blasco JJ; Riesco-Miranda JA; Altet-Gomez N; Barrueco M; Oyagüez I; Rejas J;
Int J Chron Obstruct Pulmon Dis; 2015; 10():2027-36. PubMed ID: 26451100
[TBL] [Abstract][Full Text] [Related]
17. Smoking cessation and development of respiratory health in smokers screened with normal spirometry.
Kotz D; Wesseling G; Aveyard P; van Schayck OC
Respir Med; 2011 Feb; 105(2):243-9. PubMed ID: 20850286
[TBL] [Abstract][Full Text] [Related]
18. Do COPD treatment guidelines correctly address the treatment of smoking?
Jiménez Ruiz CA; Riesco Miranda JA
Arch Bronconeumol; 2016 Dec; 52(12):581-582. PubMed ID: 27259360
[No Abstract] [Full Text] [Related]
19. The cost-effectiveness of an extended course (12+12 weeks) of varenicline plus brief counselling compared with other reimbursed smoking cessation interventions in Belgium, from a public payer perspective.
Knight C; Marbaix S; Annemans L; Prignot J; Bowrin K
Acta Clin Belg; 2012; 67(6):416-22. PubMed ID: 23340147
[TBL] [Abstract][Full Text] [Related]
20. Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.
Jiménez-Ruiz CA; Fagerström KO
Monaldi Arch Chest Dis; 2013 Mar; 79(1):27-32. PubMed ID: 23741943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
